The Latest Cardiac and Vascular News
The company plans to develop Lilly’s first-in-class clinical stage anti-angiopoietin-like 3/8 monoclonal antibody for treatment of atherosclerotic cardiovascular disease and potentially other conditions OXFORD, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kyttaro announces that it has entered into an agreement for the worldwide […]
PALM SPRINGS, Calif. and MOUNTAIN VIEW, Calif., March 31, 2022 /PRNewswire/ — Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, and Lark Health today announced that DOHC will offer Lark Heart Health, a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease (ASCVD) […]
New Program Will Provide Real-Time Coaching to Support the Prevention and Management of Atherosclerotic Cardiovascular Disease and Coronary Artery Disease MOUNTAIN VIEW, Calif., March 16, 2022 /PRNewswire/ — Lark Health today announced the development of a novel AI-driven program for the prevention and management […]
Study evaluates obicetrapib, a novel cholesteryl ester transfer protein (CETP) inhibitor, as an adjunct to diet and maximally tolerated lipid-lowering therapy Company is expected to complete enrollment in 2022 and announce data in the first quarter of 2024 NAARDEN, Netherlands–(BUSINESS […]
KANSAS CITY, Mo., Aug. 23, 2018 (GLOBE NEWSWIRE) — Cerner, a global leader in health care technology, collaborated with Duke Clinical Research Institute to develop an atherosclerotic cardiovascular disease (ASCVD) Risk Calculator app, designed as a tool to increase communication […]
